180 related articles for article (PubMed ID: 32703715)
21. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
22. Patient experiences at diagnosis and psychological well-being in prostate cancer: A Finnish national survey.
Lehto US; Helander S; Taari K; Aromaa A
Eur J Oncol Nurs; 2015 Jun; 19(3):220-9. PubMed ID: 25547457
[TBL] [Abstract][Full Text] [Related]
23. Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy.
Kim SH; Seong DH; Yoon SM; Choi YD; Choi E; Song H
Eur J Oncol Nurs; 2017 Oct; 30():84-90. PubMed ID: 29031319
[TBL] [Abstract][Full Text] [Related]
24. A pilot randomised controlled trial of a multimodal supportive care (ThriverCare) intervention for managing unmet supportive care needs in men with metastatic prostate cancer on hormonal treatment and their partner/caregivers.
Paterson C; Primeau C; Nabi G
Eur J Oncol Nurs; 2018 Dec; 37():65-73. PubMed ID: 30473053
[TBL] [Abstract][Full Text] [Related]
25. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
[TBL] [Abstract][Full Text] [Related]
26. A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHS.
Bourke L; Turner R; Greasley R; Sutton E; Steed L; Smith D; Brown J; Kelly B; Hulme C; Greenfield D; Persad R; Farrin A; Hewison J; Rosario DJ;
PLoS One; 2018; 13(7):e0197606. PubMed ID: 29975707
[TBL] [Abstract][Full Text] [Related]
27. Men's help-seeking in the first year after diagnosis of localised prostate cancer.
Hyde MK; Newton RU; Galvão DA; Gardiner RA; Occhipinti S; Lowe A; Wittert GA; Chambers SK
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 27111695
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of educational and psychological survivorship interventions to improve health-related quality of life outcomes for men with prostate cancer on androgen deprivation therapy: a systematic review.
Sara SA; Heneka N; Green A; Chambers SK; Dunn J; Terry VR
BMJ Open; 2024 May; 14(5):e080310. PubMed ID: 38777593
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis.
Logan L; Toohey K; Kavanagh PS; Paterson C; McKune AJ
Semin Oncol Nurs; 2020 Oct; 36(5):151067. PubMed ID: 33010982
[TBL] [Abstract][Full Text] [Related]
30. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study.
Smith AB; King M; Butow P; Luckett T; Grimison P; Toner GC; Stockler M; Hovey E; Stubbs J; Hruby G; Gurney H; Turner S; Alam M; Cox K; Olver I
Psychooncology; 2013 Nov; 22(11):2557-64. PubMed ID: 23825010
[TBL] [Abstract][Full Text] [Related]
31. Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.
Chipperfield K; Fletcher J; Millar J; Brooker J; Smith R; Frydenberg M; Burney S
Psychooncology; 2013 Oct; 22(10):2169-76. PubMed ID: 23483679
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinic.
Lintz K; Moynihan C; Steginga S; Norman A; Eeles R; Huddart R; Dearnaley D; Watson M
Psychooncology; 2003 Dec; 12(8):769-83. PubMed ID: 14681951
[TBL] [Abstract][Full Text] [Related]
33. Validation of the Supportive Care Needs Survey-short form 34 with a simplified response format in men with prostate cancer.
Schofield P; Gough K; Lotfi-Jam K; Aranda S
Psychooncology; 2012 Oct; 21(10):1107-12. PubMed ID: 21800397
[TBL] [Abstract][Full Text] [Related]
34. Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer.
Smith DP; Supramaniam R; King MT; Ward J; Berry M; Armstrong BK
J Clin Oncol; 2007 Jun; 25(18):2560-6. PubMed ID: 17577034
[TBL] [Abstract][Full Text] [Related]
35. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
Ott C; Fulton MK
J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
[TBL] [Abstract][Full Text] [Related]
36. Indications and Complications of Androgen Deprivation Therapy.
Fankhauser CD; Wettstein MS; Reinhardt M; Gessendorfer A; Mostafid H; Hermanns T
Semin Oncol Nurs; 2020 Aug; 36(4):151042. PubMed ID: 32773255
[TBL] [Abstract][Full Text] [Related]
37. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
39. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.
Lubeck DP; Grossfeld GD; Carroll PR
Urology; 2001 Aug; 58(2 Suppl 1):94-100. PubMed ID: 11502459
[TBL] [Abstract][Full Text] [Related]
40. Impact of Androgen Deprivation Therapy on Sexual and Hormonal Function in Patients Receiving Radiation Therapy for Prostate Cancer.
Kushnir T; Gofrit ON; Elkayam R; Paluch-Shimon S; Lawrence YR; Weiss L; Symon Z
Isr Med Assoc J; 2016 Jan; 18(1):49-53. PubMed ID: 26964281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
